Oppenheimer Maintains Outperform on MannKind, Raises Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Steven Lichtman has maintained an 'Outperform' rating on MannKind (NASDAQ:MNKD) and raised the price target from $10 to $12.
August 28, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Oppenheimer has reaffirmed its 'Outperform' rating for MannKind and increased the price target from $10 to $12, indicating a positive outlook.
The increase in price target from $10 to $12 by Oppenheimer suggests a positive outlook for MannKind's stock, likely leading to a short-term price increase. The 'Outperform' rating indicates confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100